Congress vs FDA on New RU-486 Regs

More than 70 members of Congress have sent a letter to the Food and Drug Administration (FDA) seeking information regarding the recent loosening of regulations of a dangerous abortion-inducing drug known as Mifeprex or RU-486. is reporting on a letter sent by Rep. Chris Smith (R-N.J.) and Sen. James Lankford (R-Okla.) and signed by 73 lawmakers who are expressing concern about a recent change in guidelines for the administration of RU-486. The new guidelines reduce the dosage from 600 to 200 milligrams, decrease the number of required doctor visits from three to two, and allow the pill to be taken from seven to 10 weeks of pregnancy.

“This powerful abortion drug has been associated with serious adverse events including hemorrhaging, severe infections and even deaths of mothers who have taken it,” the lawmakers say in a April 25 letter sent to FDA Commissioner Robert Califf.

The letter also pointed out that the original approval process for the drug was “extremely controversial.”

“At the start of the Clinton Administration, President Clinton issued anExecutive Order instructing the FDA to reevaluate the status of the abortion drug,” the letter stated. “Then-FDA Commissioner Kessler even urged the European patent-holder, Roussel Uclaf, to submit an application for approval of mifepristone.”

It continues: “When mainstream drug manufacturers refused to bring this baby-killing drug to the United States, abortion proponents created Danco Laboratories for the sole purpose of distributing the abortion drug in the United States. Finally, the drug was pushed through the approval process in the final months of the Clinton administration.”

Lawmakers have now requested more information about the drug and its adverse effects, including “any reported deaths associated with mifepristone through December 2015.”

The letter also requested that the FDA Commissioner provide “a copy of all documents, studies and other evidence used to assess the safety and efficacy of the Mifeprex (mifepristone) changes announced on March 30, 2016” and “a copy of all communications between you, or any member of the FDA staff, and the White House and/or the Office of the Secretary of HHS, regarding mifepristone, Mifeprex, RU-486 or ‘medication abortion.’”

Rep. Chris Smith (R-NJ) told CNS that he believes the president is bowing to pressure from his “abortion cronies” and is putting the health and lives of women and children at risk.

““The Obama Administration’s gift to the abortion industry disregards the safety and lives of women. Not only is mifepristone used to kill babies, it is a poison that has harmed and even killed women,” he said.

“Abortion advocates are celebrating FDA’s expansion of ‘medication abortion,’ but women who have suffered the trauma of a mifepristone abortion know that it is not ‘medication’– this chemical poison is not designed to heal, or cure, or mitigate pain,” he added.

Instead, it is all about killing.

Lawmakers are asking the FDA to submit the requested materials no later than May 20.

© All Rights Reserved, Living His Life Abundantly®/Women of Grace® 


Comments are closed.